A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria
A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria
Recruiting · NCT06148792 · Registry updated 2025-07-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 3 | 2025-07-18 | NCT06148792 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arba Minch General Hospital | Arba Minch | Ethiopia | 4 |
| Dr Marcus Lacerda | Manaus | Brazil | 2 |
| Dr Moses Laman and Dr Brioni Moore | Alexishafen | Papua New Guinea | 1 |
| Puskesmas Hanura | Hanura | Indonesia | 1 |